4 Largecap Low PEG Ratio Stocks in Lower 52-Week Range to Watch for Future Multibagger Potential: HDFC Bank, Sun Pharma, Shriram Finance and Polycab
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
HDFC Bank Rs 683.30. Sun Pharma Rs 1,761. Shriram Finance Rs 841.10. Polycab Rs 7,745. Market caps from Rs 1.25 lakh crore to Rs 11.05 lakh crore. Data as of 29 Oct 2026.
Quick Answer
HDFC Bank, Sun Pharma, Shriram Finance and Polycab are the 4 picks in this low PEG ratio stocks in lower 52-week range watchlist, with market caps between Rs 1.25 lakh crore and Rs 11.05 lakh crore. HDFC Bank stands out for the lowest PE of the group at 13.40, while Sun Pharma offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. PE ratios run from 13.40 to 43.02, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
Low PEG ratio stocks in lower 52-week range to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. HDFC Bank, Sun Pharma, Shriram Finance and Polycab meet that test, with market caps from Rs 1.25 lakh crore to Rs 11.05 lakh crore and HDFC Bank offering the lowest PE of the group at 13.40. Each of these companies has a PEG ratio below 1.5 and a share price in the lower 40 per cent of its 52-week range, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a PEG ratio below 1.5 and a share price in the lower 40 per cent of its 52-week range, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening low PEG ratio stocks in lower 52-week range usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Low PEG Ratio Stocks in Lower 52-Week Range and Why Do They Attract Multibagger Interest?
Low PEG ratio stocks in lower 52-week range are shares of large companies whose valuation is low compared with their profit growth and whose share price sits in the lower part of its range for the last year, a mix of value and a lower entry point. The four here cover private banking, pharmaceuticals, vehicle finance and cables.
A low PEG ratio shows that profit growth is ahead of the price paid for earnings, and a share price in the lower part of its yearly range gives buyers a more comfortable entry point. Within low PEG ratio stocks in lower 52-week range, the four companies show rising profit. In low PEG ratio stocks in lower 52-week range, each of the four also posted growth in the latest quarter. For low PEG ratio stocks in lower 52-week range, both FY26 and the latest quarter showed growth. Whichever way you read low PEG ratio stocks in lower 52-week range, the common thread is rising profit backed by complete financial data. With low PEG ratio stocks in lower 52-week range, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for low PEG ratio stocks in lower 52-week range are complete. Read each company’s latest results and exchange filings before acting on low PEG ratio stocks in lower 52-week range.
Low PEG Ratio Stocks in Lower 52-Week Range at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 29 October 2026. HDFC Bank has the lowest PE of the group at 13.40, while Polycab posts the highest return on equity at 22.25%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| HDFC Bank | 683.30 | 11,05,240 | 13.40 | 11.94 | 13.14% | 1.84 | 680.20 to 1,020.50 |
| Sun Pharmaceutical Industries | 1,761 | 4,23,148 | 34.92 | 36.42 | 13.74% | 5.06 | 1,583.70 to 2,046.90 |
| Shriram Finance | 841.10 | 2,08,485 | 18.42 | 17.68 | 15.21% | 1.98 | 662.25 to 1,153.70 |
| Polycab India | 7,745 | 1,24,977 | 43.02 | 49.96 | 22.25% | 10.41 | 6,663.00 to 10,126.00 |
HDFC Bank: 20.04% Profit CAGR Since FY22
HDFC Bank is India’s largest private sector bank by assets and serves retail, business and corporate customers through a wide branch and digital network. It reported FY26 total income of Rs 4,95,462.81 crore, up 5.21% year on year, and net profit of Rs 79,219.46 crore, up 7.87%. Net profit has compounded at 20.04% a year since FY22, while total income has grown 31.11% a year.
In the September 2026 quarter, total income rose 9.11% to Rs 1,29,358.69 crore and net profit grew 5.76% to Rs 21,537.09 crore. Domestic institutions raised their holding from 36.26% in September 2025 to 43.63% in September 2026. The stock trades at a PE of 13.40 against an industry PE of 11.94, with a return on equity of 13.14%. The dividend yield is 2.16%.
Sun Pharma: 35.75% Profit CAGR Since FY22
Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 34.92 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.
Shriram Finance: 38.64% Profit CAGR Since FY22
Shriram Finance is a major NBFC focused on commercial vehicle, small business and personal loans. It reported FY26 total income of Rs 48,192.65 crore, up 15.13% year on year, and net profit of Rs 10,004.20 crore, up 6.16%. Net profit has compounded at 38.64% a year since FY22, while total income has grown 25.75% a year.
In the June 2026 quarter, total income rose 16.26% to Rs 13,418.74 crore and net profit grew 59.95% to Rs 3,447.26 crore. The share price has gained 239.61% over five years and 40.91% over the past year. Domestic institutions raised their holding from 18.66% in September 2025 to 19.90% in June 2026. The stock trades at a PE of 18.42 against an industry PE of 17.68, with a return on equity of 15.21%.
Polycab: 33.79% Profit CAGR Since FY22
Polycab India is a leading maker of wires and cables in India, with a growing fast-moving electrical goods business. It reported FY26 revenue of Rs 29,120.04 crore, up 28.76% year on year, and net profit of Rs 2,708.43 crore, up 32.41%. Net profit has compounded at 33.79% a year since FY22, while revenue has grown 24.06% a year. Operating margin was 14.69% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
The stock trades at a PE of 43.02 against an industry PE of 49.96, below the sector average, with a return on equity of 22.25%. In the June 2026 quarter, revenue rose 38.90% to Rs 8,314.65 crore and net profit grew 32.84% to Rs 796.65 crore. The share price has gained 230.55% over five years. Foreign investors raised their holding from 11.44% in June 2025 to 19.00% in June 2026.
Low PEG Ratio Stocks in Lower 52-Week Range: Financial Comparison on Growth and Margins
The table compares scale and growth across these low PEG ratio stocks in lower 52-week range. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| HDFC Bank | 4,95,462.81 | 79,219.46 | 5.21% | 31.11% | 20.04% |
| Sun Pharma | 61,673.94 | 11,564.52 | 12.69% | 11.62% | 35.75% |
| Shriram Finance | 48,192.65 | 10,004.20 | 15.13% | 25.75% | 38.64% |
| Polycab | 29,120.04 | 2,708.43 | 28.76% | 24.06% | 33.79% |
Check the Univest Screener for live data on these low PEG ratio stocks in lower 52-week range
Institutional Holding in HDFC Bank, Sun Pharma, Shriram Finance and Polycab
Institutional holding shows who is backing these low PEG ratio stocks in lower 52-week range alongside the promoter. The table uses the latest reported quarter for each. HDFC Bank has the deepest institutional backing, with FII and DII together holding 83.03% as of September 2026. Domestic institutions increased their holding over the past year in HDFC Bank (from 36.26% to 43.63%), Sun Pharma (from 20.23% to 22.27%) and Shriram Finance (from 18.66% to 19.90%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| HDFC Bank | Nil | 39.40% | 43.63% | 16.97% | September 2026 |
| Sun Pharma | 52.68% | 14.36% | 22.27% | 10.70% | September 2026 |
| Shriram Finance | 20.30% | 54.77% | 19.90% | 5.04% | June 2026 |
| Polycab | 61.46% | 19.00% | 7.62% | 11.92% | June 2026 |
Risks to Weigh in Low PEG Ratio Stocks in Lower 52-Week Range
Being careful with low PEG ratio stocks in lower 52-week range means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: HDFC Bank trades at a PE of 13.40 against an industry PE of 11.94, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Low PEG Ratio Stocks in Lower 52-Week Range
Picking from low PEG ratio stocks in lower 52-week range comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (11.94 to 49.96) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track HDFC Bank, Sun Pharma, Shriram Finance and Polycab live prices.
Conclusion
Among low PEG ratio stocks in lower 52-week range, HDFC Bank stands out for the lowest PE of the group at 13.40, Sun Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06, Shriram Finance for the fastest profit growth, 38.64% a year since FY22 and Polycab for the highest return on equity at 22.25%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing low PEG ratio stocks in lower 52-week range should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Low PEG Ratio Stocks in Lower 52-Week Range to Watch
Which are the best low PEG ratio stocks in lower 52-week range to watch for multibagger potential?
Ans. HDFC Bank, Sun Pharma, Shriram Finance and Polycab are the 4 names this list highlights, with market caps of Rs 11,05,240 crore, Rs 4,23,148 crore, Rs 2,08,485 crore and Rs 1,24,977 crore respectively. HDFC Bank is notable for the lowest PE of the group at 13.40. Sun Pharma stands out for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Shriram Finance offers the fastest profit growth, 38.64% a year since FY22. Polycab brings the highest return on equity at 22.25%. These are watchlist names for low PEG ratio stocks in lower 52-week range, not recommendations, so match each one to your own risk profile and time horizon.
Is Polycab a good stock for long-term investors?
Ans. Polycab has a return on equity of 22.25%, a PE of 43.02 against an industry PE of 49.96 and a market cap of Rs 1,24,977 crore. Net profit has compounded at 33.79% a year since FY22, and FY26 revenue rose 28.76% while June 2026 quarter net profit grew 32.84%. Long-term returns in low PEG ratio stocks in lower 52-week range depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Shriram Finance become a multibagger from here?
Ans. Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in low PEG ratio stocks in lower 52-week range requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 18.42 against an industry PE of 17.68, valuation should be checked against that growth before investing.
What is the market cap of HDFC Bank, Sun Pharma, Shriram Finance and Polycab?
Ans. As of 29 October 2026, HDFC Bank has a market cap of Rs 11,05,240 crore, Sun Pharma has a market cap of Rs 4,23,148 crore, Shriram Finance has a market cap of Rs 2,08,485 crore and Polycab has a market cap of Rs 1,24,977 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on low PEG ratio stocks in lower 52-week range.
What are the risks of investing in low PEG ratio stocks in lower 52-week range?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. HDFC Bank trades at a PE of 13.40 against an industry PE of 11.94, so earnings growth needs to hold up.
Is HDFC Bank trading below its industry PE?
Ans. HDFC Bank trades at a PE of 13.40 against an industry PE of 11.94. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 20.04% a year since FY22 and FY26 revenue rose 5.21%) and balance sheet strength before drawing a conclusion.
How much do institutions hold in HDFC Bank, Sun Pharma, Shriram Finance and Polycab?
Ans. As of the latest reported quarter, FII and DII together hold 83.03% of HDFC Bank (39.40% and 43.63%), 36.63% of Sun Pharma (14.36% and 22.27%), 74.67% of Shriram Finance (54.77% and 19.90%) and 26.62% of Polycab (19.00% and 7.62%). Rising institutional holding is a useful signal in low PEG ratio stocks in lower 52-week range, though it should be read with earnings trends rather than on its own.
